Naples Money Management LLC acquired a new stake in The Allstate Co. (NYSE:ALL – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 888 shares of the insurance provider’s stock, valued at approximately $124,000.
Other large investors have also bought and sold shares of the company. Annis Gardner Whiting Capital Advisors LLC bought a new position in Allstate in the third quarter valued at about $25,000. Turtle Creek Wealth Advisors LLC bought a new position in Allstate in the fourth quarter valued at about $36,000. First Capital Advisors Group LLC. bought a new position in Allstate in the second quarter valued at about $29,000. Venturi Wealth Management LLC raised its position in Allstate by 152.7% in the fourth quarter. Venturi Wealth Management LLC now owns 278 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 168 shares during the last quarter. Finally, RVW Wealth LLC bought a new position in Allstate in the third quarter valued at about $33,000. 76.47% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, CAO John C. Pintozzi sold 4,000 shares of the stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total transaction of $637,880.00. Following the sale, the chief accounting officer now owns 10,736 shares of the company’s stock, valued at approximately $1,712,069.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Allstate news, insider John E. Dugenske sold 31,000 shares of the stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total value of $5,276,200.00. Following the completion of the sale, the insider now owns 63,731 shares in the company, valued at approximately $10,847,016.20. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CAO John C. Pintozzi sold 4,000 shares of the stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total value of $637,880.00. Following the completion of the sale, the chief accounting officer now owns 10,736 shares of the company’s stock, valued at approximately $1,712,069.92. The disclosure for this sale can be found here. 1.80% of the stock is currently owned by insiders.
Allstate Stock Performance
Allstate (NYSE:ALL – Get Free Report) last announced its quarterly earnings data on Thursday, February 8th. The insurance provider reported $5.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.87 by $1.95. The firm had revenue of $14.83 billion during the quarter, compared to the consensus estimate of $12.69 billion. Allstate had a positive return on equity of 2.67% and a negative net margin of 0.33%. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the company earned ($1.36) EPS. Research analysts expect that The Allstate Co. will post 13.5 EPS for the current fiscal year.
Allstate Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Monday, March 4th were given a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 2.13%. The ex-dividend date of this dividend was Friday, March 1st. This is a boost from Allstate’s previous quarterly dividend of $0.89. Allstate’s dividend payout ratio is currently -296.77%.
Analyst Ratings Changes
A number of brokerages have recently issued reports on ALL. HSBC upgraded Allstate from a “hold” rating to a “buy” rating and raised their price objective for the stock from $158.00 to $190.00 in a research report on Thursday, March 28th. Morgan Stanley raised their price objective on Allstate from $187.00 to $190.00 and gave the stock an “overweight” rating in a research report on Monday. JPMorgan Chase & Co. raised their price objective on Allstate from $172.00 to $185.00 and gave the stock an “overweight” rating in a research report on Monday, April 8th. Piper Sandler raised their price objective on Allstate from $172.00 to $188.00 and gave the stock an “overweight” rating in a research report on Monday, April 1st. Finally, Evercore ISI lifted their target price on Allstate from $166.00 to $173.00 and gave the stock an “in-line” rating in a report on Thursday, April 11th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $173.71.
Get Our Latest Stock Report on Allstate
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
- Five stocks we like better than Allstate
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Comprehensive Analysis of PayPal Stock
- Canada Bond Market Holiday: How to Invest and Trade
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- The “How” and “Why” of Investing in 5G Stocks
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.